Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 7Radiotherapy 5Magnetic Resonance Spectroscopy 5pembrolizumab 4Specimen Handling 4Radiation 3motexafin gadolinium 2Radiotherapy, Intensity-Modulated 2Radiosurgery 2Fluorouracil 2Biopsy 2zimberelimab 1peposertib 1olaparib 1ipatasertib 1dl1520 1adavosertib 1Surgical Procedures, Operative 1Resistance Training 1Protons 1Proton Therapy 1Platinum 1Pemetrexed 1Paclitaxel 1Nutritional Status 1NVP-BKM120 1Laser Therapy 1L 778,123 1Immunohistochemistry 1Hyperthermia, Induced 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Laryngeal Neoplasms × dl1520 × Clear all
NCT00006106 2013-07-10

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Withdrawn
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡